715 related articles for article (PubMed ID: 25892679)
1. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial.
AVERT Trial Collaboration group
Lancet; 2015 Jul; 386(9988):46-55. PubMed ID: 25892679
[TBL] [Abstract][Full Text] [Related]
2. A Very Early Rehabilitation Trial after stroke (AVERT): a Phase III, multicentre, randomised controlled trial.
Langhorne P; Wu O; Rodgers H; Ashburn A; Bernhardt J
Health Technol Assess; 2017 Sep; 21(54):1-120. PubMed ID: 28967376
[TBL] [Abstract][Full Text] [Related]
3. Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial.
Palmer R; Dimairo M; Cooper C; Enderby P; Brady M; Bowen A; Latimer N; Julious S; Cross E; Alshreef A; Harrison M; Bradley E; Witts H; Chater T
Lancet Neurol; 2019 Sep; 18(9):821-833. PubMed ID: 31397288
[TBL] [Abstract][Full Text] [Related]
4. Effect of early mobilisation on long-term cognitive impairment in critical illness in the USA: a randomised controlled trial.
Patel BK; Wolfe KS; Patel SB; Dugan KC; Esbrook CL; Pawlik AJ; Stulberg M; Kemple C; Teele M; Zeleny E; Hedeker D; Pohlman AS; Arora VM; Hall JB; Kress JP
Lancet Respir Med; 2023 Jun; 11(6):563-572. PubMed ID: 36693400
[TBL] [Abstract][Full Text] [Related]
5. Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.
Gusev EI; Martynov MY; Nikonov AA; Shamalov NA; Semenov MP; Gerasimets EA; Yarovaya EB; Semenov AM; Archakov AI; Markin SS;
Lancet Neurol; 2021 Sep; 20(9):721-728. PubMed ID: 34418399
[TBL] [Abstract][Full Text] [Related]
6. Economic Evaluation Plan (EEP) for A Very Early Rehabilitation Trial (AVERT): An international trial to compare the costs and cost-effectiveness of commencing out of bed standing and walking training (very early mobilization) within 24 h of stroke onset with usual stroke unit care.
Sheppard L; Dewey H; Bernhardt J; Collier JM; Ellery F; Churilov L; Tay-Teo K; Wu O; Moodie M;
Int J Stroke; 2016 Jun; 11(4):492-4. PubMed ID: 26936861
[TBL] [Abstract][Full Text] [Related]
7. Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trial.
Schaller SJ; Anstey M; Blobner M; Edrich T; Grabitz SD; Gradwohl-Matis I; Heim M; Houle T; Kurth T; Latronico N; Lee J; Meyer MJ; Peponis T; Talmor D; Velmahos GC; Waak K; Walz JM; Zafonte R; Eikermann M;
Lancet; 2016 Oct; 388(10052):1377-1388. PubMed ID: 27707496
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of GABA
Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
[TBL] [Abstract][Full Text] [Related]
9. Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial.
ATTEND Collaborative Group
Lancet; 2017 Aug; 390(10094):588-599. PubMed ID: 28666682
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of non-immersive virtual reality exercising in stroke rehabilitation (EVREST): a randomised, multicentre, single-blind, controlled trial.
Saposnik G; Cohen LG; Mamdani M; Pooyania S; Ploughman M; Cheung D; Shaw J; Hall J; Nord P; Dukelow S; Nilanont Y; De Los Rios F; Olmos L; Levin M; Teasell R; Cohen A; Thorpe K; Laupacis A; Bayley M;
Lancet Neurol; 2016 Sep; 15(10):1019-27. PubMed ID: 27365261
[TBL] [Abstract][Full Text] [Related]
11. Early mobilisation post-stroke: a systematic review and meta-analysis of individual participant data.
Rethnam V; Langhorne P; Churilov L; Hayward KS; Herisson F; Poletto SR; Tong Y; Bernhardt J
Disabil Rehabil; 2022 Apr; 44(8):1156-1163. PubMed ID: 32673130
[TBL] [Abstract][Full Text] [Related]
12. An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial.
Bornstein NM; Saver JL; Diener HC; Gorelick PB; Shuaib A; Solberg Y; Thackeray L; Savic M; Janelidze T; Zarqua N; Yarnitsky D; Molina CA;
Lancet; 2019 Jul; 394(10194):219-229. PubMed ID: 31133406
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of a phase III international randomised controlled trial of very early mobilisation after stroke (AVERT).
Gao L; Sheppard L; Wu O; Churilov L; Mohebbi M; Collier J; Bernhardt J; Ellery F; Dewey H; Moodie M;
BMJ Open; 2019 May; 9(5):e026230. PubMed ID: 31118178
[TBL] [Abstract][Full Text] [Related]
14. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial.
Mackenzie IS; Hawkey CJ; Ford I; Greenlaw N; Pigazzani F; Rogers A; Struthers AD; Begg AG; Wei L; Avery AJ; Taggar JS; Walker A; Duce SL; Barr RJ; Dumbleton JS; Rooke ED; Townend JN; Ritchie LD; MacDonald TM;
Lancet; 2022 Oct; 400(10359):1195-1205. PubMed ID: 36216006
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
Hess DC; Wechsler LR; Clark WM; Savitz SI; Ford GA; Chiu D; Yavagal DR; Uchino K; Liebeskind DS; Auchus AP; Sen S; Sila CA; Vest JD; Mays RW
Lancet Neurol; 2017 May; 16(5):360-368. PubMed ID: 28320635
[TBL] [Abstract][Full Text] [Related]
16. High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial.
Ginsberg MD; Palesch YY; Hill MD; Martin RH; Moy CS; Barsan WG; Waldman BD; Tamariz D; Ryckborst KJ;
Lancet Neurol; 2013 Nov; 12(11):1049-58. PubMed ID: 24076337
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.
Ford GA; Bhakta BB; Cozens A; Hartley S; Holloway I; Meads D; Pearn J; Ruddock S; Sackley CM; Saloniki EC; Santorelli G; Walker MF; Farrin AJ
Lancet Neurol; 2019 Jun; 18(6):530-538. PubMed ID: 31122493
[TBL] [Abstract][Full Text] [Related]
18. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial.
VITATOPS Trial Study Group
Lancet Neurol; 2010 Sep; 9(9):855-65. PubMed ID: 20688574
[TBL] [Abstract][Full Text] [Related]
19. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
Logallo N; Novotny V; Assmus J; Kvistad CE; Alteheld L; Rønning OM; Thommessen B; Amthor KF; Ihle-Hansen H; Kurz M; Tobro H; Kaur K; Stankiewicz M; Carlsson M; Morsund Å; Idicula T; Aamodt AH; Lund C; Næss H; Waje-Andreassen U; Thomassen L
Lancet Neurol; 2017 Oct; 16(10):781-788. PubMed ID: 28780236
[TBL] [Abstract][Full Text] [Related]
20. [Very early mobilisation in cases of acute stroke].
Fure B; Holte HH; Hov L; Vist GE; Kateraas LH; Indredavik B
Tidsskr Nor Laegeforen; 2018 Oct; 138(17):. PubMed ID: 30378408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
